NIH-funded research R01 grant

Reducing scarring to help salivary glands regenerate

Official title: Remediating fibrosis for salivary gland regeneration

Funded at State University of New York at Albany · NIH-11307580 · Data updated 2026-11-12

This research aims to reduce scar tissue in salivary glands to help people with dry mouth after radiation or Sjögren’s syndrome regain gland function.

More Fibrosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionState University of New York at Albany
NIH-funded
Lab location1 site (Albany, United States)
Project startApril 1, 2019
Project endMarch 31, 2029
Funding year2026
Award (this year)$656,893
NIH project number5R01DE027953-08
Project IDNIH-11307580 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be people with reduced salivary function and evidence of gland fibrosis following head-and-neck radiation or due to Sjögren’s syndrome.

Less likely to help

People whose dry mouth is caused mainly by medications or who have end-stage, irreversible loss of gland tissue are less likely to benefit from these approaches.

What this research studies

The team is studying the scar-forming cells and the signals that make them produce excess extracellular matrix in salivary glands. They use single-cell RNA sequencing to pinpoint a PDGFRα+ stromal cell population that drives fibrosis and examine how TGFβ signaling changes the gland matrix. The researchers will test whether changing those signals and using scaffold-supported cell transplants can reverse fibrosis in laboratory models and restore gland structure. The goal is to develop approaches that could eventually be offered to people with radiation- or autoimmune-related salivary gland damage.

Why it matters

Potential benefit: If successful, this work could restore salivary gland structure and improve saliva production for people with radiation- or Sjögren’s-related dry mouth.

How similar studies have gone: Prior lab and animal work has identified fibrogenic PDGFRα+ cells and TGFβ’s role, but scaffold-mediated reversal of salivary fibrosis is largely untested in humans.

Where this research is happening

  • State University of New York at Albany
    Albany, United States
    Active

Researchers

  • Principal investigator: Larsen, Melinda — State University of New York at Albany
  • Study coordinator: Larsen, Melinda

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.